This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)
Penile implants and lengthening surgeries, equally, have left some men fulfilled and proud, and others flabbergasted and dismayed
Some sources suggest earliest potential availability in 2026-27 if trials go well and regulatory approval follows
Proactive stress management After having a baby, theres a lot on your plate, and stress is normal